The 4th Inflammasome Therapeutics Summit is a conference dedicated to the latest scientific progress and current challenges in drug development for inflammatory driven diseases.
The 4th Inflammasome Therapeutics Summit covers topics such as:
- The Molecular Mechanisms of the Inflammasome
- Clinical Progress for Inflammasome Targeted Therapies
- What is Happening Upstream & Downstream of the Inflammasome
- Advances in Developing More Translatable Pre-Clinical Models
- Developments in Novel Therapeutic Modalities Effectively Targeting the Inflammasome
- Advancing in Biomarkers for Assessing Target Engagement
- COVID Induced Inflammation – The Role of the Inflammasome
- Novel Therapeutic Targets
- Further Analysing the NLRP-3 Inflammasome & the Potential it Holds
- Investigating Novel Inflammasome Inhibitors
- The Detail of Cytokine Pathways & Cell Death
The 4th Inflammasome Therapeutics Summit is being held in Boston on 29 Nov - 01 Dec, 2022.